Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01092104
What this trial is testing

A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 52
Testing effectiveness (Phase 2)Ended earlyNCT00823979
What this trial is testing

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

Who this might be right for
HIV-1
Pfizer 105
Early research (Phase 1)Study completedNCT00712530
What this trial is testing

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Who this might be right for
HIV Infection
Genetic Immunity 9
Not applicableStudy completedNCT01074931
What this trial is testing

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Who this might be right for
HIV-1 Infections
Abbott 98
Large-scale testing (Phase 3)Study completedNCT03311945
What this trial is testing

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM

Who this might be right for
HIV InfectionsHIV-1-infectionHIV Seropositivity
Judit Pich 33
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Early research (Phase 1)UnknownNCT01881581
What this trial is testing

Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS

Who this might be right for
Acquired Immunodeficiency Syndrome
Centers for Disease Control and Prevention, China 56
Not applicableStudy completedNCT00000759
What this trial is testing

Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 675
Testing effectiveness (Phase 2)UnknownNCT02441231
What this trial is testing

Probiotic Visbiome for Inflammation and Translocation in HIV II

Who this might be right for
HIV-1 Infection
University Health Network, Toronto 36
Not applicableStudy completedNCT00002172
What this trial is testing

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

Who this might be right for
HIV Infections
The Immune Response Corporation
Not applicableStudy completedNCT00001681
What this trial is testing

A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations

Who this might be right for
HIV Infections
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT00001119
What this trial is testing

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 288
Post-approval studies (Phase 4)Study completedNCT01026454
What this trial is testing

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

Who this might be right for
HSV InfectionHIV Infection
University of Washington 32
Testing effectiveness (Phase 2)Study completedNCT03593538
What this trial is testing

Effects of Metformin During Nicotine Withdrawal

Who this might be right for
SmokingHIV-1-infection
University of Pennsylvania 80
Not applicableStudy completedNCT00777426
What this trial is testing

HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia

Who this might be right for
HIV Infections
SEARCH Research Foundation 60
Early research (Phase 1)UnknownNCT03588715
What this trial is testing

Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

Who this might be right for
HIVHIV/AIDSHIV-1 Infection
Luis Montaner 15
Testing effectiveness (Phase 2)WithdrawnNCT00415649
What this trial is testing

Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Very early researchLooking for participantsNCT04883255
What this trial is testing

Cannabis Use, Cognition, and the Endocannabinoid System in HIV

Who this might be right for
HIV-1-infection
University of California, San Diego 138
Testing effectiveness (Phase 2)Looking for participantsNCT06774872
What this trial is testing

Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully

Who this might be right for
HIV-1-infection
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 408
Not applicableEnded earlyNCT00937729
What this trial is testing

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Who this might be right for
HIV1 InfectionHIV Infections
University Hospital, Rouen 4
Next Page